An in‐frame HRAS fusion gene was identified in a head and neck primary tumour (RNH1–HRAS) that leads to increased levels of HRAS expression 66; however, no additional HRAS fusion genes were detected in primary breast cancers. Here, RNH1 is linked to breast carcinoma.